Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
| Status: | Completed |
|---|---|
| Conditions: | Cervical Cancer, Cervical Cancer, Cervical Cancer, Cancer, Cancer, Other Indications, Women's Studies, Endometrial Cancer |
| Therapuetic Areas: | Oncology, Other, Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | July 2008 |
| End Date: | May 2010 |
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
RATIONALE: Understanding how well patients comply with their treatment regimen may help
doctors determine best treatment and ongoing care for future patients.
PURPOSE: This phase I study is looking at compliance with vaginal dilation therapy in women
who have undergone radiation therapy for stage IB, stage IIA, stage IIB, stage IIIA, or
stage IIIB cervical cancer or stage IA, stage IB, stage IIA, or stage IIB endometrial
cancer.
doctors determine best treatment and ongoing care for future patients.
PURPOSE: This phase I study is looking at compliance with vaginal dilation therapy in women
who have undergone radiation therapy for stage IB, stage IIA, stage IIB, stage IIIA, or
stage IIIB cervical cancer or stage IA, stage IB, stage IIA, or stage IIB endometrial
cancer.
OBJECTIVES:
Primary
- To determine adherence to vaginal dilation therapy after radiotherapy in patients with
early-stage IB grade 2-IIIB cervical cancer or stage IA grade 3-IIB endometrial cancer.
- To identify demographic, medical, and psychosocial factors associated with adherence to
recommendations for vaginal dilation in these patients.
- To describe the sexual, marital, and non-marital dyadic functioning of these patients.
OUTLINE: Patients from the IMPAC registry in Radiation Oncology at the University Hospitals
Case Medical Center, Ireland Cancer Center complete questionnaires online or by mail.
Questionnaires include the Vaginal Dilation Adherence questionnaire, the Sexual
Function-Vaginal Changes Questionnaire, the Dyadic Satisfaction questionnaire, and the
Physician/Nurse Recommendation of Vaginal Dilation questionnaire.
Primary
- To determine adherence to vaginal dilation therapy after radiotherapy in patients with
early-stage IB grade 2-IIIB cervical cancer or stage IA grade 3-IIB endometrial cancer.
- To identify demographic, medical, and psychosocial factors associated with adherence to
recommendations for vaginal dilation in these patients.
- To describe the sexual, marital, and non-marital dyadic functioning of these patients.
OUTLINE: Patients from the IMPAC registry in Radiation Oncology at the University Hospitals
Case Medical Center, Ireland Cancer Center complete questionnaires online or by mail.
Questionnaires include the Vaginal Dilation Adherence questionnaire, the Sexual
Function-Vaginal Changes Questionnaire, the Dyadic Satisfaction questionnaire, and the
Physician/Nurse Recommendation of Vaginal Dilation questionnaire.
DISEASE CHARACTERISTICS:
- History of early-stage IB grade 2-IIIB cervical cancer or stage IA grade 3-IIB
endometrial cancer
- Meets the following criteria:
- Received radiotherapy for this disease
- Treated within the last 3 years and followed for at least 6 months
PATIENT CHARACTERISTICS:
- Able to read and understand English
- Currently with or without a sexual partner
- No history of other cancers
- No other potentially life-threatening disease
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
We found this trial at
8
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Cleveland, Ohio 44106
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials